EOLS
NASDAQ · Pharmaceuticals
Evolus Inc
$7.86
-0.15 (-1.87%)
Open$8.00
Previous Close$8.01
Day High$8.00
Day Low$7.81
52W High$9.31
52W Low$3.86
Volume—
Avg Volume901.6K
Market Cap529.06M
P/E Ratio—
EPS$-0.53
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+552.5% upside
Current
$7.86
$7.86
Target
$51.29
$51.29
$37.24
$51.29 avg
$70.77
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 311.07M | 246.90M | 74.40M |
| Net Income | -54,053,600 | -38,612,778 | 20.76M |
| Profit Margin | -17.4% | -16.5% | 27.9% |
| EBITDA | -27,620,647 | -20,826,743 | 38.85M |
| Free Cash Flow | — | — | 15.01M |
| Rev Growth | +26.0% | +26.0% | +16.8% |
| Debt/Equity | 22.00 | 22.00 | 0.90 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |